Recital 7, Commission Implementing Regulation (EU) No 1045/2011 of 19 October 2011 concerning the n…

In forcesince 19 Oct 2011

During the evaluation of this active substance, concerns were identified. Those concerns were, in particular, the following. It was not possible to perform a reliable consumer exposure assessment as data were missing concerning the presence and toxicity of the metabolite sulfanilamide, as well as concerning the presence of other potentially significant metabolites that were not analysed in the available residue trials and processing studies. Furthermore, no data was available on the toxicological relevance of the impurities in the technical specification of the active substance. In addition, a high risk to birds was identified.